Hard to believe it's been a whole month since the #CHIBioprocessingSummit, but it has! Thank you to everyone who attended the presentation by Huda Naas on Navigating the Evolution of Potency Assays and for all those who stopped by our booth to say hi. On demand access is available now if you are interested, or reach out any time to chat #genetherapy at [email protected]. See you next year in #Boston! https://lnkd.in/eqYsS33
Ascend Advanced Therapies
Biotechnology Research
Ascend is a gene therapy development partner with a flexible platform featuring industry-leading analytics.
About us
Ascend is gene to GMP partner with deep expertise in gene therapy development and commercialization. We offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business. To set a new standard in the industry, we have invested in a world-class analytical toolkit within our flexible and scalable AAV platform of next-gen technologies, all built to find the perfect balance of yield and quality for each process. Let’s aim higher and develop the next wave of accessible life-saving therapies together!
- Website
-
https://www.ascend-adv.com/
External link for Ascend Advanced Therapies
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2021
- Specialties
- gene therapy
Locations
-
Primary
London, GB
-
Munich, DE
-
14193 NW 119th Terrace
Alachua, Florida 32615, US
Employees at Ascend Advanced Therapies
Updates
-
It's just about go time! Are you ready to hear Ahmed Youssef and Ivana Petrovic Koshmak, PhD of Sartorius Stedim Biotech share insights on AAV process optimization and scale-up, including strategies to maximize AAV yield and ensure consistency across scales? You have a few minutes to sign up for the #webinar, but no fear if today's schedule will not allow it. You'll be able to catch us on demand to learn more about optimizing #genetherapy production or feel free to reach out any time to chat at [email protected].
Join our webinar to learn about scalable platforms and their benefits throughout an AAV product’s lifecycle: https://sar.to/ad97c #SimplifyingProgress #InThisTogether #CellandGeneTherapy
-
Just two weeks from now is a talk you will not want to miss! You're invited to join our own Ahmed Youssef as he participates in this BioProcess International #webinar with Sartorius Stedim Biotech on targeted AAV optimization for #genetherapy. How can leveraging a DOE approach maximize AAV yield and ensure consistency across scales? Register here to find out:
-
This week in Lisbon, find us in the Innovation Zone during #ATE24. Jason King will be out and about and ready to chat #genetherapy. Will your team be there? Find us in the app or message us at [email protected] to connect. https://lnkd.in/eskryRqS
-
We hope everyone's week is closing well as we settle into September! What better way to round out this week than some insight from our CFO, Wes McConnell on the #genetherapy market and the role outsourcing plays in keeping progress moving? https://lnkd.in/ddrHsVFr
-
We will be doing our best to hold on to the end of summer at #ATE 2024 next week from 10 to 12 September in Lisbon, Portugal (hosted by the team at Phacilitate)! Looking forward to a great time networking and listening to critical #genetherapy #industry updates onsite. Interested in connecting? Find us on the app or reach out here to set time to chat!
-
Our team is committed to helping #genetherapy developers find success, whether it is a project or a full program. We know how critical people are to this goal, and are thrilled to have people like Michael Pinaud on the team. He recently joined to further optimize our global #operations to develop the next wave of accessible life-saving therapies together. https://lnkd.in/giZwjQV5
-
Our Executive team grew by two! Welcome to the team, Scott Broughton and Michael Pinaud! We are thrilled to have you here, helping to guide the next steps in our journey supporting #genetherapy developers as they change lives. https://lnkd.in/giZwjQV5
-
How much can design of experiment (DoE) and an integrated strategy impact #genetherapy success? What does an iterative data-driven rational approach aligned with high-throughput screening and transcriptomics deliver? Our own Chris Reid, Markus Hörer, and Mo Mandegar discuss improving recombinant adeno-associated viral (rAAV) vector manufacturing for commercialization in this recent Cell & Gene Therapy Insights paper. https://lnkd.in/dyj7PWhx
-
We may be biased, but look at this great team! From left to right, Karim Pirani, Geeta Iyer, Huda Naas (yesterday's speaker), and Charles St. James, M.S are representing us right at the #CHIBioprocessingSummit in booth TT5. You can't miss us when you come in, so if you are at the show, stop by and say hello. Thank you to Rizwan Chaudhrey for the awesome photo! We appreciate your time!